Evidence map›Paper›PMID 41188270›Full record

ArticleScientific reports2025

Postsynthetic modification of amine functionalized MIL-101(Cr) loaded with Pd nanoparticles for sustainable Suzuki coupling reactions.

Mehdi Abroudi, Azadeh Tadjarodi, Zolfaghar Rezvani, Modarres Dehghani, Afsaneh Mollahosseini, Seyed Masoud Seyed Ahmadian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mehdi AbroudiResearch Laboratory of Inorganic Materials Synthesis, Department of Chemistry, Iran University of Science and Technology (IUST), Tehran, 16846-13114, Iran.
Azadeh TadjarodiResearch Laboratory of Inorganic Materials Synthesis, Department of Chemistry, Iran University of Science and Technology (IUST), Tehran, 16846-13114, Iran. tajarodi@iust.ac.ir.
Zolfaghar RezvaniDepartment of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran.
Modarres DehghaniResearch Laboratory of Inorganic Materials Synthesis, Department of Chemistry, Iran University of Science and Technology (IUST), Tehran, 16846-13114, Iran.
Afsaneh MollahosseiniResearch Laboratory of Spectroscopy & Micro and Nano Extraction, Department of Chemistry, Iran University of Science and Technology (IUST), Tehran, 16846-13114, Iran.
Seyed Masoud Seyed AhmadianPhysical Chemistry Laboratory, Department of Chemistry, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MIL-101(Cr) metal-organic frameworks (MOFs) possess advantageous properties, such as high surface area and porosity, which render them effective as catalytic supports. In this study, MIL-101(Cr) powder was functionalized with putrescine (PUT) via post-synthetic modification (PSM). Subsequently, a novel strategy was employed to incorporate palladium nanoparticles into the functionalized MIL-101(Cr) framework. The resulting Pd-loaded, functionalized MIL-101(Cr) catalysts were assessed for their catalytic efficiency in Suzuki-Miyaura carbon-carbon cross-coupling reactions. In particular, these catalysts were used to couple phenylboronic acid with various aryl halides (Ar-X, where X = I, Br, Cl, F). To maximize catalytic performance, key reaction parameters including the amount of catalyst, the amount and type of solvent, and the reaction time were optimized. The catalyst exhibited excellent reusability and stability, maintaining its efficiency over multiple reaction cycles.

Indexed as

C–C cross-coupling reactionMIL-101(Cr)Palladium nanoparticlesPost-synthesis (PSM) strategyPutrescine

Identifiers

PMID41188270
PMCPMC12586664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.